EFTA01087638Set 9
2015-10-015p3,969w
expects to present clinical data
from the second-generation I/O agents such as CD137, KIR and LAG-3
in 2016. In addition, multiple novel agents such as IDO, OX40
https://www.justice.gov/epstein/files/DataSet%209/EFTA01087638.pdf